IVVM:BATS-BlackRock ETF Trust II - iShares Large Cap Moderate Buffer ETF (USD)

ETF | Others |

Last Closing

USD 31.53

Change

-0.16 (-0.50)%

Market Cap

N/A

Volume

9.00K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-21 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
FBTC Fidelity Wise Origin Bitcoin T..

+1.40 (+1.50%)

USD 20.46B
INDA iShares MSCI India ETF

-0.04 (-0.07%)

USD 8.92B
PAVE Global X U.S. Infrastructure D..

-0.84 (-1.99%)

USD 7.74B
BUFR First Trust Cboe Vest Fund of ..

-0.34 (-1.10%)

USD 6.29B
BOXX Alpha Architect 1-3 Month Box ..

+0.02 (+0.02%)

USD 6.29B
ARKB ARK 21Shares Bitcoin ETF

+1.55 (+1.45%)

USD 4.99B
BBUS JPMorgan BetaBuilders U.S. Equ..

-1.78 (-1.66%)

USD 4.22B
KNG FT Cboe Vest S&P 500® Dividen..

-1.24 (-2.48%)

USD 3.55B
GSUS Goldman Sachs MarketBeta US Eq..

-1.27 (-1.55%)

USD 2.41B
IFRA iShares U.S. Infrastructure ET..

-0.94 (-1.94%)

USD 2.23B

ETFs Containing IVVM

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.83% 80% B- 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.83% 80% B- 77% C+
Trailing 12 Months  
Capital Gain 11.76% 90% A- 88% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.76% 88% B+ 85% B
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 7.04% 69% C- 67% D+
Dividend Return 7.04% 63% D 61% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 8.15% 57% F 61% D-
Risk Adjusted Return 86.31% 79% B- 80% B-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike